Jason P Rhodes
Director at Dyne Therapeutics, Inc. (DYN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $129M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 17SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 268,3543,801,128 held (−7%) | $26.20 | $7.0M | -36.5% |
| Aug 17SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 94,4151,045,735 held (−8%) | $26.20 | $2.5M | -36.5% |
| Aug 17SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 63,643751,411 held (−8%) | $26.20 | $1.7M | -36.5% |
| Aug 17SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 1,359,6742,441,454 held (−36%) | $25.00 | $34.0M | -33.4% |
| Aug 17SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 478,377567,358 held (−46%) | $25.00 | $12.0M | -33.4% |
| Aug 17SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 322,465428,946 held (−43%) | $25.00 | $8.1M | -33.4% |
| Jul 8SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 253,0394,223,448 held (−6%) | $22.79 | $5.8M | -27.0% |
| Jul 8SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 127,1821,217,537 held (−9%) | $22.79 | $2.9M | -27.0% |
| Jul 8SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 100,019875,912 held (−10%) | $22.79 | $2.3M | -27.0% |
| Jul 8SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 124,3794,099,069 held (−3%) | $23.17 | $2.9M | -28.2% |
| Jul 8SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 29,5874,069,482 held (−1%) | $23.62 | $699K | -29.6% |
| Jul 8SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 62,5431,154,994 held (−5%) | $23.17 | $1.4M | -28.2% |
| Jul 8SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 14,8441,140,150 held (−1%) | $23.62 | $351K | -29.6% |
| Jul 8SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 49,193826,719 held (−6%) | $23.17 | $1.1M | -28.2% |
| Jul 8SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 11,665815,054 held (−1%) | $23.62 | $276K | -29.6% |
| Jul 8SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 5,0002,962 held (−63%) | $23.61 | $118K | -29.5% |
| Jun 30SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 162,9544,579,456 held (−3%) | $21.28 | $3.5M | -21.8% |
| Jun 30SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 81,9031,396,475 held (−6%) | $21.28 | $1.7M | -21.8% |
| Jun 30SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 64,4111,016,633 held (−6%) | $21.28 | $1.4M | -21.8% |
| Jun 30SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 102,9694,476,487 held (−2%) | $21.14 | $2.2M | -21.3% |
| Jun 30SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 51,7561,344,719 held (−4%) | $21.14 | $1.1M | -21.3% |
| Jun 30SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 40,702975,931 held (−4%) | $21.14 | $860K | -21.3% |
| Jun 26SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 77,8554,805,639 held (−2%) | $21.13 | $1.6M | -21.2% |
| Jun 26SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 39,1311,510,157 held (−3%) | $21.13 | $827K | -21.2% |
| Jun 26SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 30,7741,106,036 held (−3%) | $21.13 | $650K | -21.2% |
| Jun 26SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 50,5304,755,109 held (−1%) | $21.02 | $1.1M | -20.8% |
| Jun 26SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 25,3971,484,760 held (−2%) | $21.02 | $534K | -20.8% |
| Jun 26SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 19,9731,086,063 held (−2%) | $21.02 | $420K | -20.8% |
| Jun 26SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 12,6994,742,410 held (−0%) | $21.10 | $268K | -21.1% |
| Jun 26SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 6,3821,478,378 held (−0%) | $21.10 | $135K | -21.1% |
| Jun 26SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 5,0191,081,044 held (−0%) | $21.10 | $106K | -21.1% |
| May 6SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 3,1361,574,270 held (−0%) | $18.00 | $56K | -7.6% |
| May 6SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 6,2414,933,196 held (−0%) | $18.00 | $112K | -7.6% |
| May 6SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 618,450 held (−1%) | $18.00 | $1K | -7.6% |
| May 6SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 2,4661,156,457 held (−0%) | $18.00 | $44K | -7.6% |
| May 6SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 3,0561,571,214 held (−0%) | $18.03 | $55K | -7.7% |
| May 6SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 6,0814,927,115 held (−0%) | $18.03 | $110K | -7.7% |
| May 6SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 608,390 held (−1%) | $18.03 | $1K | -7.7% |
| May 6SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 2,4031,154,054 held (−0%) | $18.03 | $43K | -7.7% |
| May 6SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 21,9261,549,288 held (−1%) | $18.18 | $399K | -8.5% |
| May 6SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 43,6214,883,494 held (−1%) | $18.18 | $793K | -8.5% |
| May 6SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 4287,962 held (−5%) | $18.18 | $8K | -8.5% |
| May 6SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 17,2441,136,810 held (−1%) | $18.18 | $313K | -8.5% |
| Apr 30SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 59,8701,577,432 held (−4%) | $18.38 | $1.1M | -9.5% |
| Apr 30SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 119,1154,939,489 held (−2%) | $18.38 | $2.2M | -9.5% |
| Apr 30SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 1,1708,512 held (−12%) | $18.38 | $22K | -9.5% |
| Apr 30SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 47,0821,158,944 held (−4%) | $18.38 | $865K | -9.5% |
| Apr 30SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 261,577,406 held (−0%) | $19.00 | $494 | -12.4% |
| Apr 30SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 524,939,437 held (−0%) | $19.00 | $988 | -12.4% |
| Apr 30SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 18,511 held (−0%) | $19.00 | $19 | -12.4% |
| Apr 30SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 211,158,923 held (−0%) | $19.00 | $399 | -12.4% |
| Apr 27SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 19,2611,719,356 held (−1%) | $19.19 | $370K | -13.3% |
| Apr 27SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 38,3225,221,857 held (−1%) | $19.19 | $735K | -13.3% |
| Apr 27SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 37711,286 held (−3%) | $19.19 | $7K | -13.3% |
| Apr 27SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 15,1481,270,556 held (−1%) | $19.19 | $291K | -13.3% |
| Apr 27SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 36,3451,683,011 held (−2%) | $18.48 | $672K | -10.0% |
| Apr 27SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 72,3105,149,547 held (−1%) | $18.48 | $1.3M | -10.0% |
| Apr 27SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 71010,576 held (−6%) | $18.48 | $13K | -10.0% |
| Apr 27SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 28,5831,241,973 held (−2%) | $18.48 | $528K | -10.0% |
| Apr 27SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 45,7091,637,302 held (−3%) | $18.15 | $830K | -8.3% |
| Apr 27SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 90,9435,058,604 held (−2%) | $18.15 | $1.7M | -8.3% |
| Apr 27SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 8949,682 held (−8%) | $18.15 | $16K | -8.3% |
| Apr 27SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 35,9471,206,026 held (−3%) | $18.15 | $652K | -8.3% |
| Apr 22SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 71,6761,886,751 held (−4%) | $20.06 | $1.4M | -17.0% |
| Apr 22SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 142,6045,554,904 held (−3%) | $20.06 | $2.9M | -17.0% |
| Apr 22SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 1,40114,561 held (−9%) | $20.06 | $28K | -17.0% |
| Apr 22SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 56,3681,402,200 held (−4%) | $20.06 | $1.1M | -17.0% |
| Apr 22SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 71,4991,815,252 held (−4%) | $19.51 | $1.4M | -14.7% |
| Apr 22SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 142,2535,412,651 held (−3%) | $19.51 | $2.8M | -14.7% |
| Apr 22SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 1,39813,163 held (−10%) | $19.51 | $27K | -14.7% |
| Apr 22SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 56,2281,345,972 held (−4%) | $19.51 | $1.1M | -14.7% |
| Apr 22SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 7691,814,483 held (−0%) | $20.05 | $15K | -17.0% |
| Apr 22SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 1,5305,411,121 held (−0%) | $20.05 | $31K | -17.0% |
| Apr 22SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 1513,148 held (−0%) | $20.05 | $301 | -17.0% |
| Apr 22SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 6051,345,367 held (−0%) | $20.05 | $12K | -17.0% |
| Apr 22SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 75,8661,738,617 held (−4%) | $19.68 | $1.5M | -15.4% |
| Apr 22SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 150,9425,260,179 held (−3%) | $19.68 | $3.0M | -15.4% |
| Apr 22SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 1,48511,663 held (−11%) | $19.68 | $29K | -15.4% |
| Apr 22SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 59,6631,285,704 held (−4%) | $19.68 | $1.2M | -15.4% |
- Sell
Director Jason P Rhodes sold $7.0M of DYN at $26.20 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Jason P Rhodes sold $2.5M of DYN at $26.20 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Jason P Rhodes sold $1.7M of DYN at $26.20 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Jason P Rhodes sold $34.0M of DYN at $25.00 — cuts the stake by 36%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Jason P Rhodes sold $12.0M of DYN at $25.00 — cuts the stake by 46%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Jason P Rhodes sold $8.1M of DYN at $25.00 — cuts the stake by 43%; pre-scheduled 10b5-1 plan sale.